InflaRx NV (NASDAQ:IFRX)
| 1.40 BATS BZX Real-Time Price As of 10:27am ET |  -0.04 / -2.78%Today’s Change | 1.14 Today|||52-Week Range 7.25 | -54.84% Year-to-Date |
Latest IFRX News | Press Releases
| Here's Why InflaRx N.V. (IFRX) Looks Ripe for Bottom Fishing Dec 01 / Zacks.com - Paid Partner Content | After Plunging -17.65% in 4 Weeks, Here's Why the Trend Might Reverse for InflaRx N.V. (IFRX) Nov 28 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.44 |
| Today’s open | 1.43 |
| Day’s range | 1.39 - 1.43 |
| Volume | 1,814 |
| Average volume (3 months) | 304,233 |
| Market cap | $83.6M |
Data as of 10:27am ET, 12/11/2023
Growth & Valuation
| Earnings growth (last year) | +45.90% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.67 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ALTAltimmune Inc | -0.54 | -8.28% |
| ---- | ||
| BPTHBio Path Holdings In... | 0.00 | 0.00% |
| SNGXSoligenix Inc | -0.07 | -10.55% |
Data as of 11:10am ET, 12/11/2023
Financials
| Next reporting date | March 21, 2024 |
| EPS forecast (this quarter) | $0.17 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$31.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Jena, Thueringen |
Forecasts
